Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 )

Ramadevi Nimmanapalli; Mercedes Porosnicu; Diep Nguyen; Elizabeth Worthington; Erica O'Bryan; Charles Perkins; Kapil Bhalla

doi:10.1158/1078-0432.CCR-19-1602

Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 )

Ramadevi Nimmanapalli, Mercedes Porosnicu, Diep Nguyen, Elizabeth Worthington, Erica O'Bryan, Charles Perkins, Kapil Bhalla

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The editors are publishing this note to alert readers to concerns about this article (1). Figure 5A and B use the same b-actin control panel. The b-actin control panel in Fig. 3A is similar to lanes 2 through 6 in the b-actin panels in Fig. 5A and B. The original data are no longer available for review, and the authors stand by the conclusions of the article.

Original language	English (US)
Pages (from-to)	4195
Number of pages	1
Journal	Clinical Cancer Research
Volume	25
Issue number	13
DOIs	https://doi.org/10.1158/1078-0432.CCR-19-1602
State	Published - 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-19-1602

Fingerprint

Dive into the research topics of 'Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 )'. Together they form a unique fingerprint.

Cite this

Nimmanapalli, R., Porosnicu, M., Nguyen, D., Worthington, E., O'Bryan, E., Perkins, C., & Bhalla, K. (2019). Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 ). Clinical Cancer Research, 25(13), 4195. https://doi.org/10.1158/1078-0432.CCR-19-1602

Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 ). / Nimmanapalli, Ramadevi; Porosnicu, Mercedes; Nguyen, Diep et al.
In: Clinical Cancer Research, Vol. 25, No. 13, 2019, p. 4195.

Research output: Contribution to journal › Comment/debate › peer-review

Nimmanapalli, R, Porosnicu, M, Nguyen, D, Worthington, E, O'Bryan, E, Perkins, C & Bhalla, K 2019, 'Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 )', Clinical Cancer Research, vol. 25, no. 13, pp. 4195. https://doi.org/10.1158/1078-0432.CCR-19-1602

Nimmanapalli R, Porosnicu M, Nguyen D, Worthington E, O'Bryan E, Perkins C et al. Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 ). Clinical Cancer Research. 2019;25(13):4195. doi: 10.1158/1078-0432.CCR-19-1602

@article{bd06f203f5f841a5bf37de706e26709f,

title = "Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 )",

abstract = "The editors are publishing this note to alert readers to concerns about this article (1). Figure 5A and B use the same b-actin control panel. The b-actin control panel in Fig. 3A is similar to lanes 2 through 6 in the b-actin panels in Fig. 5A and B. The original data are no longer available for review, and the authors stand by the conclusions of the article.",

author = "Ramadevi Nimmanapalli and Mercedes Porosnicu and Diep Nguyen and Elizabeth Worthington and Erica O'Bryan and Charles Perkins and Kapil Bhalla",

note = "Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",

year = "2019",

doi = "10.1158/1078-0432.CCR-19-1602",

language = "English (US)",

volume = "25",

pages = "4195",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "13",

}

TY - JOUR

T1 - Erratum

T2 - Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 )

AU - Nimmanapalli, Ramadevi

AU - Porosnicu, Mercedes

AU - Nguyen, Diep

AU - Worthington, Elizabeth

AU - O'Bryan, Erica

AU - Perkins, Charles

AU - Bhalla, Kapil

PY - 2019

Y1 - 2019

N2 - The editors are publishing this note to alert readers to concerns about this article (1). Figure 5A and B use the same b-actin control panel. The b-actin control panel in Fig. 3A is similar to lanes 2 through 6 in the b-actin panels in Fig. 5A and B. The original data are no longer available for review, and the authors stand by the conclusions of the article.

AB - The editors are publishing this note to alert readers to concerns about this article (1). Figure 5A and B use the same b-actin control panel. The b-actin control panel in Fig. 3A is similar to lanes 2 through 6 in the b-actin panels in Fig. 5A and B. The original data are no longer available for review, and the authors stand by the conclusions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85069262195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069262195&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-19-1602

DO - 10.1158/1078-0432.CCR-19-1602

M3 - Comment/debate

C2 - 31263034

AN - SCOPUS:85069262195

SN - 1078-0432

VL - 25

SP - 4195

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 13

ER -

Erratum: Editor's Note: Cotreatment with STI-571 enhances tumor necrosis factor a-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive Human acute leukemia cells (Clin Cancer Res (2019) 25:4195 )

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this